- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
A review article of inflammatory bowel disease treatment and pharmacogenomics ; volume:12 ; number:1 ; day:30 ; month:3 ; year:2023 ; pages:1-19 ; date:12.2023
Beni-Suef University Journal of Basic and Applied Sciences / Ǧāmiʿat Banī-Suwaif ; 12, Heft 1 (30.3.2023), 1-19, 12.2023
- Creator
-
Eltantawy, Nashwa
El-Zayyadi, Islam Abd El-Hamid
Elberry, Ahmed A.
Salah, Layla M.
Abdelrahim, Mohamed E. A.
Kassem, Amira B.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43088-023-00361-0
- URN
-
urn:nbn:de:101:1-2023081521005655736317
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Eltantawy, Nashwa
- El-Zayyadi, Islam Abd El-Hamid
- Elberry, Ahmed A.
- Salah, Layla M.
- Abdelrahim, Mohamed E. A.
- Kassem, Amira B.
- SpringerLink (Online service)
Other Objects (12)
Pharmacogenomics
New treatment options for inflammatory bowel diseases
Inflammatory bowel disease
6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease
Biologic treatment of Japanese patients with inflammatory bowel disease
The pharmacogenomics journal
Pharmacogenomics and toxicogenomics
Pharmacogenomics and toxicogenomics
Smart bionanomaterials for treatment and diagnosis of inflammatory bowel disease
Is Psoriasis Treatment a Risk Factor for Inflammatory Bowel Disease?
Morning light treatment for inflammatory bowel disease: a clinical trial
Pharmacogenomics
New treatment options for inflammatory bowel diseases
Inflammatory bowel disease
6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease
Biologic treatment of Japanese patients with inflammatory bowel disease
The pharmacogenomics journal
Pharmacogenomics and toxicogenomics
Pharmacogenomics and toxicogenomics
Smart bionanomaterials for treatment and diagnosis of inflammatory bowel disease
Is Psoriasis Treatment a Risk Factor for Inflammatory Bowel Disease?
Morning light treatment for inflammatory bowel disease: a clinical trial
Pharmacogenomics
New treatment options for inflammatory bowel diseases
Inflammatory bowel disease
6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease
Biologic treatment of Japanese patients with inflammatory bowel disease
The pharmacogenomics journal
Pharmacogenomics and toxicogenomics
Pharmacogenomics and toxicogenomics
Smart bionanomaterials for treatment and diagnosis of inflammatory bowel disease
Is Psoriasis Treatment a Risk Factor for Inflammatory Bowel Disease?